- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 7, 2024 | 26.28M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $19.78M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $17.85M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $10.18M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $8.99M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $25.43M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $25.17M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $51.3M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $49.9M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $74.75M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $73.47M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $1.42M |
| Revenue | Q1 2024 · Mar 31, 2024 | $39.86M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $49.81M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 26.94M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $8.73K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $2.92M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $45.84M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $43.32M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.09 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.09 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $7.91M |
| Net Income | Q1 2024 · Mar 31, 2023 | $2.53M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $3.15M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $11.41M |